These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 19705413

  • 1. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 2. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M.
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [Abstract] [Full Text] [Related]

  • 3. T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible.
    Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H.
    J Leukoc Biol; 2009 Aug; 86(2):273-81. PubMed ID: 19401389
    [Abstract] [Full Text] [Related]

  • 4. Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line.
    Bahbouhi B, Berthelot L, Pettré S, Michel L, Wiertlewski S, Weksler B, Romero IA, Miller F, Couraud PO, Brouard S, Laplaud DA, Soulillou JP.
    J Leukoc Biol; 2009 Nov; 86(5):1049-63. PubMed ID: 19696154
    [Abstract] [Full Text] [Related]

  • 5. Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis.
    Tischner D, Weishaupt A, van den Brandt J, Müller N, Beyersdorf N, Ip CW, Toyka KV, Hünig T, Gold R, Kerkau T, Reichardt HM.
    Brain; 2006 Oct; 129(Pt 10):2635-47. PubMed ID: 16921176
    [Abstract] [Full Text] [Related]

  • 6. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M, Schreiner B, Kieseier BC, Neuhaus O, Dichgans J, Hartung HP, Weller M, Wiendl H.
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients.
    Feger U, Luther C, Poeschel S, Melms A, Tolosa E, Wiendl H.
    Clin Exp Immunol; 2007 Mar; 147(3):412-8. PubMed ID: 17302889
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of regulatory T cells in multiple sclerosis.
    Zozulya AL, Wiendl H.
    Nat Clin Pract Neurol; 2008 Jul; 4(7):384-98. PubMed ID: 18578001
    [Abstract] [Full Text] [Related]

  • 12. Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
    Teleshova N, Pashenkov M, Huang YM, Söderström M, Kivisäkk P, Kostulas V, Haglund M, Link H.
    J Neurol; 2002 Jun; 249(6):723-9. PubMed ID: 12111306
    [Abstract] [Full Text] [Related]

  • 13. Similar sensitivity of regulatory T cells towards CD95L-mediated apoptosis in patients with multiple sclerosis and healthy individuals.
    Fritzsching B, Korporal M, Haas J, Krammer PH, Suri-Payer E, Wildemann B.
    J Neurol Sci; 2006 Dec 21; 251(1-2):91-7. PubMed ID: 17092518
    [Abstract] [Full Text] [Related]

  • 14. Mitoxantrone does not restore the impaired suppressive function of natural regulatory T cells in patients suffering from multiple sclerosis. A longitudinal ex vivo and in vitro study.
    Putzki N, Kumar M, Kreuzfelder E, Grosse-Wilde H, Diener HC, Limmroth V.
    Eur Neurol; 2009 Dec 21; 61(1):27-32. PubMed ID: 18948697
    [Abstract] [Full Text] [Related]

  • 15. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
    Korporal M, Haas J, Balint B, Fritzsching B, Schwarz A, Moeller S, Fritz B, Suri-Payer E, Wildemann B.
    Arch Neurol; 2008 Nov 21; 65(11):1434-9. PubMed ID: 19001161
    [Abstract] [Full Text] [Related]

  • 16. The CD8 T cell in multiple sclerosis: suppressor cell or mediator of neuropathology?
    Johnson AJ, Suidan GL, McDole J, Pirko I.
    Int Rev Neurobiol; 2007 Nov 21; 79():73-97. PubMed ID: 17531838
    [Abstract] [Full Text] [Related]

  • 17. IL-2 receptor and HLA class II antigens on cerebrospinal fluid cells of patients with multiple sclerosis and other neurological diseases.
    Tournier-Lasserve E, Lyoncaen O, Roullet E, Bach MA.
    Clin Exp Immunol; 1987 Mar 21; 67(3):581-6. PubMed ID: 3038441
    [Abstract] [Full Text] [Related]

  • 18. [Expression of interleukin 2 receptor and class II histocompatibility antigens on lymphocytes of the cerebrospinal fluid in patients with multiple sclerosis and other neurological diseases].
    Tournier-Lasserve E, Lyon-Caen O, Roullet E, Bach MA.
    Pathol Biol (Paris); 1987 Mar 21; 35(3):303-6. PubMed ID: 3108835
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS, Calder VL, Feldmann M, Davison AN.
    Clin Exp Immunol; 1985 Aug 21; 61(2):248-56. PubMed ID: 3930109
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.